Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulating splicing with small molecular inhibitors of the spliceosome
Kerstin A. Effenberger, Veronica K. Urabe, Melissa S. Jurica
Wiley Interdisciplinary Reviews - RNA (2016) Vol. 8, Iss. 2
Open Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

Alternative splicing and cancer: a systematic review
Yuanjiao Zhang, Jinjun Qian, Chunyan Gu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 296
Targeting mRNA processing as an anticancer strategy
Joana Desterro, Pedro Bak‐Gordon, Maria Carmo‐Fonseca
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 2, pp. 112-129
Closed Access | Times Cited: 161
Payload diversification: a key step in the development of antibody–drug conjugates
Louise Conilh, Lenka Sadílková, Warren Viricel, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 112
Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds
Constantin Cretu, Anant A. Agrawal, Andrew S. Cook, et al.
Molecular Cell (2018) Vol. 70, Iss. 2, pp. 265-273.e8
Open Access | Times Cited: 151
Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer
Xiang Zheng, Peng Qiu, Lujuan Wang, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 13, pp. 2442-2453
Open Access | Times Cited: 99
The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action
Lorenzo I. Finci, Xiaofeng Zhang, Xiuliang Huang, et al.
Genes & Development (2018) Vol. 32, Iss. 3-4, pp. 309-320
Open Access | Times Cited: 98
RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDB
William C. Reinhold, Sudhir Varma, Margot Sunshine, et al.
Cancer Research (2019) Vol. 79, Iss. 13, pp. 3514-3524
Open Access | Times Cited: 77
Pre-mRNA splicing-associated diseases and therapies
Sierra L. Love, Joseph D. Emerson, Kazunori Koide, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 525-538
Open Access | Times Cited: 26
RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Yufang Bao, Sirui Zhang, Xiaoyu Zhang, et al.
Cancer Research (2023) Vol. 83, Iss. 9, pp. 1490-1502
Open Access | Times Cited: 22
Targeting splicing abnormalities in cancer
Anant A. Agrawal, Lihua Yu, Peter G. Smith, et al.
Current Opinion in Genetics & Development (2017) Vol. 48, pp. 67-74
Closed Access | Times Cited: 70
Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer
Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Enrique Gómez‐Gómez, et al.
Translational research (2019) Vol. 212, pp. 89-103
Closed Access | Times Cited: 70
Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma
Juan L López-Cánovas, Mercedes del Río-Moreno, Helena García-Fernández, et al.
Cancer Letters (2020) Vol. 496, pp. 72-83
Open Access | Times Cited: 67
Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures
Jermaine L. Jenkins, Clara L. Kielkopf
Trends in Genetics (2017) Vol. 33, Iss. 5, pp. 336-348
Open Access | Times Cited: 63
Splicing and cancer: Challenges and opportunities
Patrícia P. Coltri, Maria Gabriela Pereira dos Santos, Guilherme Henrique Gatti da Silva
Wiley Interdisciplinary Reviews - RNA (2019) Vol. 10, Iss. 3
Closed Access | Times Cited: 61
The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer
Andrea Cerasuolo, Luigi Buonaguro, Luigi Buonaguro, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 51
Structural basis of intron selection by U2 snRNP in the presence of covalent inhibitors
Constantin Cretu, Patricia Gee, Xiang Liu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Introns: the “dark matter” of the eukaryotic genome
Kaitlin N. Girardini, Anouk Olthof, Rahul Kanadia
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 21
Targeting splicing factors for cancer therapy
Ariel Bashari, Zahava Siegfried, Rotem Karni
RNA (2023) Vol. 29, Iss. 4, pp. 506-515
Open Access | Times Cited: 18
Contrastive pre-training and 3D convolution neural network for RNA and small molecule binding affinity prediction
Saisai Sun, Lin Gao
Bioinformatics (2024) Vol. 40, Iss. 4
Open Access | Times Cited: 7
Light regulates nuclear detainment of intron-retained transcripts through COP1-spliceosome to modulate photomorphogenesis
Hua Zhou, Haiyue Zeng, Tingting Yan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Targeting the spliceosome machinery: A new therapeutic axis in cancer?
Béatrice Eymin
Biochemical Pharmacology (2020) Vol. 189, pp. 114039-114039
Closed Access | Times Cited: 42
Dengue Virus Non-Structural Protein 5 as a Versatile, Multi-Functional Effector in Host–Pathogen Interactions
Priya Bhatnagar, Gopinathan Pillai Sreekanth, Kaja Murali‐Krishna, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 37
Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, Sonia Alcalá, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 36
Autophagy regulation by RNA alternative splicing and implications in human diseases
Patricia González-Rodríguez, Daniel J. Klionsky, Bertrand Joseph
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities
Akila S. Venkataramany, Kathleen M. Schieffer, K Lee, et al.
Annals of Oncology (2022) Vol. 33, Iss. 6, pp. 578-592
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top